Stock Analysis

KPJ Healthcare Berhad Second Quarter 2024 Earnings: Revenues Beat Expectations

KLSE:KPJ
Source: Shutterstock

KPJ Healthcare Berhad (KLSE:KPJ) Second Quarter 2024 Results

Key Financial Results

  • Revenue: RM930.6m (up 16% from 2Q 2023).
  • Net income: RM77.6m (up 65% from 2Q 2023).
  • Profit margin: 8.3% (up from 5.9% in 2Q 2023). The increase in margin was driven by higher revenue.
earnings-and-revenue-growth
KLSE:KPJ Earnings and Revenue Growth August 30th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

KPJ Healthcare Berhad Revenues Beat Expectations

Revenue exceeded analyst estimates by 4.6%.

Looking ahead, revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Healthcare industry in Malaysia.

Performance of the Malaysian Healthcare industry.

The company's shares are down 1.6% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 1 warning sign for KPJ Healthcare Berhad that you should be aware of.

Valuation is complex, but we're here to simplify it.

Discover if KPJ Healthcare Berhad might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.